by Maria Zannes | Sep 26, 2020 | Articles, News
SEPTEMBER 26, 2020 By Douglas Brown, Authority Magazine Follow the science. Businesspeople rightfully seek to control a situation, but that does not bode well in the science field. Mother nature has a way of surprising you. Innovation is essential to a biotech...
by Maria Zannes | Sep 24, 2020 | Articles, Events, News
SEPTEMBER 24, 2020 Originally published in Medical Design & Outsourcing by Sean Whooley. Maria Zannes and her company BioAffinity Technologies are seeking to up the game on lung cancer detection. Here’s how. Maria Zannes’ path to a leading role in the...
by Maria Zannes | Aug 12, 2020 | Press Releases
Precision Completes Development of CyPath® Lung and Starts CLIA Validation of Cancer Assay for Sale as a Laboratory Developed Test (LDT) FAQ: Answers to Questions about Cypath® Lung August 12, 2020 (San Antonio, TX) bioAffinity Technologies, a privately-held biotech...
by Maria Zannes | Aug 11, 2020 | News
AUGUST 11, 2020 As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal A local pathology practice has initiated a validation study of San Antonio-based bioAffinity Technologies’ CyPath Lung early...
by Maria Zannes | Aug 4, 2020 | Events, Press Releases
AUGUST 4, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced its presentation of a poster explaining the Company’s use of flow cytometry for diagnosis of lung disease including cancer at the International Society for...
